These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28506922)

  • 21. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.
    Woolley JD; Lam O; Chuang B; Ford JM; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2015 Mar; 53():217-22. PubMed ID: 25637811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of adjunctive intranasal oxytocin in patients with schizophrenia.
    Ota M; Yoshida S; Nakata M; Yada T; Kunugi H
    Postgrad Med; 2018 Jan; 130(1):122-128. PubMed ID: 29105546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxytocin and social functioning.
    Jones C; Barrera I; Brothers S; Ring R; Wahlestedt C
    Dialogues Clin Neurosci; 2017 Jun; 19(2):193-201. PubMed ID: 28867943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxytocin in the treatment of the social deficits associated to autism spectrum disorders].
    Cachafeiro-Espino C; Vale-Martínez AM
    Rev Neurol; 2015 Nov; 61(9):421-8. PubMed ID: 26503318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
    Bowen MT; Neumann ID
    Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.
    Macdonald K; Feifel D
    Acta Neuropsychiatr; 2012 Jun; 24(3):130-46. PubMed ID: 22736892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review.
    Papadea D; Dalla C; Tata DA
    Brain Sci; 2023 Mar; 13(3):. PubMed ID: 36979271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
    Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
    Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
    Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
    JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving social perception in schizophrenia: the role of oxytocin.
    Fischer-Shofty M; Brüne M; Ebert A; Shefet D; Levkovitz Y; Shamay-Tsoory SG
    Schizophr Res; 2013 May; 146(1-3):357-62. PubMed ID: 23433504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin as Treatment for Social Cognition, Not There Yet.
    Erdozain AM; Peñagarikano O
    Front Psychiatry; 2019; 10():930. PubMed ID: 31998152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank.
    Winterton A; Bettella F; de Lange AG; Haram M; Steen NE; Westlye LT; Andreassen OA; Quintana DS
    Transl Psychiatry; 2021 Nov; 11(1):599. PubMed ID: 34824196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
    Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxytocin's effect on resting-state functional connectivity varies by age and sex.
    Ebner NC; Chen H; Porges E; Lin T; Fischer H; Feifel D; Cohen RA
    Psychoneuroendocrinology; 2016 Jul; 69():50-9. PubMed ID: 27032063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Dagani J; Sisti D; Abelli M; Di Paolo L; Pini S; Raimondi S; Rocchi MB; Saviotti FM; Scocco P; Totaro S; Balestrieri M; de Girolamo G
    Schizophr Res; 2016 Apr; 172(1-3):158-64. PubMed ID: 26883950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery.
    Gumley A; Braehler C; Macbeth A
    Br J Clin Psychol; 2014 Mar; 53(1):42-61. PubMed ID: 24588761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data extraction and statistical errors: A quantitative critique of Gumley, Braehler, and Macbeth (2014).
    Williams DR; Bürkner PC
    Br J Clin Psychol; 2017 Jun; 56(2):208-211. PubMed ID: 28217976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin and the Neurobiology of Prosocial Behavior.
    Marsh N; Marsh AA; Lee MR; Hurlemann R
    Neuroscientist; 2021 Dec; 27(6):604-619. PubMed ID: 32981445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin and potential benefits for obesity treatment.
    Olszewski PK; Klockars A; Levine AS
    Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):320-325. PubMed ID: 28590323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.